Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner.
Amyloid-β inhibits No-cGMP signaling in a CD36- and CD47-dependent manner.
复制标题
DOI:
10.1371/journal.pone.0015686
复制
发表时间:
2010-12-22
期刊:
影响因子:
3.7
通讯作者:
Roberts DD
中科院分区:
文献类型:
--
作者:
Miller TW;Isenberg JS;Shih HB;Wang Y;Roberts DD
Amyloid-β interacts with two cell surface receptors, CD36 and CD47, through which the matricellular protein thrombospondin-1 inhibits soluble guanylate cyclase activation. Here we examine whether amyloid-β shares this inhibitory activity. Amyloid-β inhibited both drug and nitric oxide-mediated activation of soluble guanylate cyclase in several cell types. Known cGMP-dependent functional responses to nitric oxide in platelets and vascular smooth muscle cells were correspondingly inhibited by amyloid-β. Functional interaction of amyloid-β with the scavenger receptor CD36 was indicated by inhibition of free fatty acid uptake via this receptor. Both soluble oligomer and fibrillar forms of amyloid-β were active. In contrast, amyloid-β did not compete with the known ligand SIRPα for binding to CD47. However, both receptors were necessary for amyloid-β to inhibit cGMP accumulation. These data suggest that amyloid-β interaction with CD36 induces a CD47-dependent signal that inhibits soluble guanylate cyclase activation. Combined with the pleiotropic effects of inhibiting free fatty acid transport via CD36, these data provides a molecular mechanism through which amyloid-β can contribute to the nitric oxide signaling deficiencies associated with Alzheimer's disease.
登录
查看更多内容
DOI:
10.1111/j.1749-6632.1997.tb48507.x
发表时间:
1997-09-26
影响因子:
5.2
作者:
Giokarini, T;Bonafini, L;Longmore, J
通讯作者:
Longmore, J
影响因子:
64.5
作者:
Arancio, O;Kiebler, M;Hawkins, RD
通讯作者:
Hawkins, RD
影响因子:
3.3
作者:
Law, A;O'Donnell, J;Quirion, R
通讯作者:
Quirion, R
影响因子:
3.3
作者:
BLASI, E;BARLUZZI, R;BISTONI, F
通讯作者:
BISTONI, F
影响因子:
3.5
作者:
Crawford, F;Soto, C;Mullan, M
通讯作者:
Mullan, M